+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A prospective clinical trial comparing low dose OKT3 prophylaxis and prednisolone cyclosporine treatment in renal transplant recipients



A prospective clinical trial comparing low dose OKT3 prophylaxis and prednisolone cyclosporine treatment in renal transplant recipients



Kidney International 43(4): 971-972




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029757254

Download citation: RISBibTeXText


Related references

Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up. Transplantation Proceedings 41(4): 1152-1155, 2009

A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transplant International 11(3): 231-236, 1998

Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results. Transplantation Proceedings 24(5): 1732-1733, 1992

Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. Transplantation Proceedings 33(1-2): 1034-1035, 2001

A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression. Transplantation Proceedings 26(4): 1985-1986, 1994

Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant. Transplant International 18(4): 419-422, 2005

Interim Analysis Of A Single-Center, Prospective, Randomized Trial Comparing Tacrolimus Versus Cyclosporine Immunosuppression Using 2 Hour Post Dose (C2) Monitoring In De Novo Liver Transplant Recipients. Transplantation Journal 78: 377-378, 2004

A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Archives of Surgery 127(1): 55-63; Discussion 63-4, 1992

VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial. Trials 15: 430, 2014

First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation. Transplantation Proceedings 24(5): 2241-2242, 1992

A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients. American Journal of Kidney Diseases 30(5): 639-645, 1997

A Randomized Trial Comparing Cyclosporine Induction With Sequential Therapy in Renal Transplant Recipients. Journal of Urology 160(6): 2299-2300, 1998

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Transplantation Proceedings 28(6): 3166-3168, 1996

Prospective trial of high-dose versus low-dose prednisolone in renal transplant patients. Transplantation Proceedings 12(2): 323-326, 1980

Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. Clinical Transplantation 21(2): 277-284, 2007